Channel:  SeroNet

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

57 Articles

A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies
Dinnon, K. H., Leist, S. R., Okuda, K., Dang, H., Fritch, E. J., Gully, K. L., Cruz, G., Evangelista, M. D., Asakura, T., Gilmore, R. C., Hawkins, P., Nakano, S., West, A., Schäfer, A., Gralinski, L. E., Everman, J. L., Sajuthi, S. P., Zweigart, M. R., Dong, S., McBride, J., Cooley, M. R., Hines, J. B., Love, M. K., Groshong, S. D., VanSchoiack, A., Phelan, S. J., Liang, Y., Hether, T., Leon, M., Zumwalt, R. E., Barton, L. M., Duval, E. J., Mukhopadhyay, S., Stroberg, E., Borczuk, A., Thorne, L. B., Sakthivel, M. K., Lee, Y. Z., Hagood, J. S., Mock, J. R., Seibold, M. A., O'Neal, W. K., Montg
10.1101/2022.02.15.480515 — Posted: 2022-02-15
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Liu, J., Chandrashekar, A., Sellers, D., Barrett, J., Lifton, M., McMahan, K., Sciacca, M., VanWyk, H., Wu, C., Yu, J., Collier, A.-r., Barouch, D. H.
10.1101/2022.01.02.22268634 — Posted: 2022-01-03
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type virus and Delta variant
Jiang, L., Driedonks, T., Lowman, M., Jong, W. S., van den Berg van Saparoea, H. B., Dhakal, S., Zhou, R., Caputo, C., Littlefield, K., Sitaras, I., Chen, M. W., Lima, G., Gololobova, O., Smith, B., Mahairaki, V., Richardson, M. R., Mulka, K. R., Lane, A. P., Klein, S. L., Pekosz, A., Brayton, C. F., Mankowski, J. L., Luirink, J., Villano, J. S., Witwer, K. W.
10.1101/2021.06.28.450181 — Posted: 2022-02-01
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Karger, A. B., Brien, J. D., Christen, J. M., Dhakal, S., Kemp, T. J., Klein, S. L., Pinto, L. A., Premkumar, L., Roback, J. D., Binder, R. A., Boehme, K. W., Boppana, S., Cordon-Cardo, C., Crawford, J. M., Daiss, J. L., Dupuis, A. P., Espino, A. M., Firpo-Betancourt, A., Forconi, C., Forrest, J. C., Girardin, R. C., Granger, D. A., Granger, S. W., Haddad, N. S., Heaney, C. D., Hunt, D. T., Kennedy, J. L., King, C. L., Krammer, F., Kruczynski, K., LaBaer, J., Lee, F. E.-H., Lee, W. T., Liu, S.-L., Lozanski, G., Lucas, T., Mendu, D. R., Moormann, A. M., Murugan, V., Okoye, N. C., Pantoja, P., P
10.1101/2022.02.27.22271399 — Posted: 2022-03-14
Neutralization and Stability of SARS-CoV-2 Omicron Variant
Cong, Z., Evans, J. P., Qu, P., Faraone, J., Zheng, Y.-M., Carlin, C., Bednash, J. S., Zhou, T., Lozanski, G., Mallampalli, R., Saif, L. J., Oltz, E. M., Mohler, P., Xu, K., Gumina, R. J., Liu, S.-L.
10.1101/2021.12.16.472934 — Posted: 2021-12-20
Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
QU, P., Faraone, J. N., Evans, J. P., Zheng, Y.-M., Carlin, C., Lozanski, G., Saif, L. J., Oltz, E. M., Gumina, R. J., Liu, S.-L.
10.1101/2022.07.21.501010 — Posted: 2022-07-22
Infectious disease dynamics and restrictions on social gathering size
Boyer, C. B., Rumpler, E., Kissler, S. M., Lipsitch, M.
10.1101/2022.01.07.21268585 — Posted: 2022-07-12

RSS  Channel RSS